Spatial navigation training using immersive VR in older adults with mild cognitive impairment
Official title: Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment
Run by Albert Einstein College of Medicine · NCT07225400 · Data updated 2026-11-12
This trial tests whether older adults with mild cognitive impairment can complete a 24-session immersive VR navigation training and whether EEG together with VR can show brain activation changes during learning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Albert Einstein College of Medicine Academic / other |
| Locations | 2 sites (Manhattan, New York and 1 other locations) |
| Status | Recruiting |
| Started | September 15, 2026 |
| Main results expected | December 23, 2027 |
| Study ends | December 23, 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07225400 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 65+ with amnestic MCI who can speak English, can walk unassisted for at least 10 minutes, agree to EEG recording, and plan to remain in the area for a year.
✕Probably not a fit
Individuals with dementia, certain medical or psychiatric conditions, mobility or sensory barriers, or contraindications to EEG may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm study in adults 65 and older with amnestic MCI. Participants will complete twenty-four 50-minute training sessions over four months while navigating a full-immersive VR maze and wearing EEG to record brain activity. The study aims to determine if at least 70% can finish the training and to explore how VR-based spatial navigation learning relates to changes in brain activation in regions involved in navigation. The intervention leverages region-specific brain information to tailor the VR maze design, with the goal of improving spatial navigation abilities and generating biomarkers of learning. The trial will be conducted at Columbia University Irving Medical Center and Albert Einstein College of Medicine with support from NIA.
Why it matters
Potential benefit: If successful, the approach could improve spatial navigation abilities in people with MCI and provide biomarkers linked to learning that may inform future interventions.
How similar studies have gone: Previous VR-based spatial navigation studies show feasibility in older adults, but this project is novel in coupling full-immersive VR navigation with EEG–based brain activation measures specific to navigation learning.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 65 and older with amnestic mild cognitive impairment (aMCI); * Can speak English; * Agrees to MoBI recording; * Normal or corrected-to-normal vision/audition; * Able to walk unassisted for 10 minutes; * Plan to be in the area for next year Exclusion Criteria: * Dementia (Memory Impairment/AD8 screen); * Medical conditions that affect participation such as vertigo and neck pain; * Hospitalization in the past six months or plans for surgery affecting participation in the next four months; * Mobility limitations solely due to musculoskeletal limitation or pain; * Terminal illness with life expectancy less than 12 months; * Presence of clinical disorders that overtly alter attention like delirium; * Active psychoses or psychiatric symptoms; * Living in nursing home; * Participation in intervention trial; * Standard contraindications to EEG including seizure medication, epilepsy, stroke, traumatic brain injury; * Pregnant women
Where it's running
-
Columbia University Irving Medical Center
Manhattan, New York, United States Recruiting -
Albert Einstein College of Medicine
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Pierfilippo De Sanctis, PhD — Albert Einstein College of Medicine
- Study coordinator: Pierfilippo De Sanctis, PhD
- Email: pierfilippo.sanctis@einsteinmed.edu
- Phone: 718-862-1828
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rural Veterans and Care Partners Walking Program
A virtual walking program is tested to see if it can help Veterans with mild cognitive impairment and their care partners in rural areas walk more each day.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
See if multimodal biomarkers can map changes from mild cognitive impairment to dementia
This observational study tests whether clinical, blood, and brain-imaging markers can tell apart stages of cognitive decline and predict progression from mild cognitive impairment to dementia in about 600 people.
-
LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment
A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.
-
Digital STEADI: A home-based digital fall prevention program for older adults
A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.